Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,406,000
+61,000 (4.54%)
Last updated: Jul 21, 2026, 11:40 AM KST
Samsung Biologics Employees
Samsung Biologics had 5,047 employees as of June 30, 2025. The number of employees increased by 277 or 5.81% since the number was reported on December 31, 2024.
Employees
5,047
Change
277
Growth
5.81%
Revenue / Employee
926.77M KRW
Profits / Employee
361.51M KRW
Market Cap
62.26T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 5,047 | 277 | 5.81% |
| Dec 31, 2024 | 4,770 | 1,884 | 65.28% |
| Dec 31, 2020 | 2,886 | 1,135 | 64.82% |
| Dec 31, 2017 | 1,751 | 413 | 30.87% |
| Dec 31, 2016 | 1,338 | - | - |
Samsung Biologics News
- 13 hours ago - Samsung Biologics (005940) Proposes $1.8 Billion Acquisition of Polypeptide Group - GuruFocus
- 17 hours ago - Samsung Biologics to Acquire Peptide Group for $1.8 Billion (SMCI) - GuruFocus
- 19 hours ago - PolyPeptide Receives CHF 1.46 Bln Samsung Offer, Posts Strong H1 Prelim. Result, Raises Guidance - Nasdaq
- 20 hours ago - Samsung Biologics to Acquire PolyPeptide Group for $1.8 Billion - GuruFocus
- 20 hours ago - Samsung Biologics (207940) Launches $1.8 Billion Cash Offer for Swiss Peptide Group - GuruFocus
- 22 hours ago - Samsung Biologics To Enter Peptide CDMO Market With CHF 1.46 Bln PolyPeptide Acquisition; Stock Down - Nasdaq
- 1 day ago - Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal - CNBC
- 1 day ago - Samsung Biologics to launch $1.8 billion all-cash bid for PolyPeptide - Reuters